View original post here: PLx Pharma Inc. Receives Nasdaq Delisting Notice
View original post here: PLx Pharma Inc. Receives Nasdaq Delisting Notice
More: Elucida Oncology to Present New Clinical and Preclinical Data at the 2023 AACR Annual Meeting
Here is the original post: Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UCART22
More here: Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023
Read the original: Aligos Therapeutics to Present Data from Chronic Hepatitis B and Hepatocellular Carcinoma Programs at the European Association for the Study of the...
Read the original post: HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023
Read the rest here: InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares
Continue reading here: Araris Biotech AG Announces Strategic Investment with Samsung Ventures
See original here: Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Operable NSCLC...
Continued here: Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment Following First-line Therapy Met...
Recent Comments